The Role of Ozone Therapy in Hepatic Fibrosis due to Biliary Tract Obstruction

Abstract

Purposes In this experimental study, we investigated the role of ozone therapy in hepatic fibrosis caused by biliary obstruction.

Materials and Methods In this study, 21 male Sprague-Dawley rats were divided equally into three groups. In the control group, only laparotomy was performed and intraperitoneal cavity is washed with 1 mL of saline. In the sham group (SG), common bile duct is binded with laparotomy and no treatment is given afterward. In the experimental group (EG) after the binding of common bile duct with laparotomy, 1 mg/kg dose and 50 mg/mL concentration of ozone were applied rectally for 21 days. Hepatic tissue sample and intracardiac blood samples were collected from all animals at postoperative 21st day with relaparatomy.

Results When we compared the experiment to SG, we detected a decrease in aspartate aminotransferase, alkaline phosphate (ALP), total bilirubin, and direct bilirubin levels in the EG, however, only the decrease in total bilirubin levels were statistically significant (p = 0.025). Histopathological examination of livers of rats in the EG showed lower level of hepatic fibrosis and inflammation. In the SG, incomplete cirrhosis was detected in 57.1% of the rats, whereas in the EG, no cirrhosis was detected. Immunohistochemically, periportal inflammation was 100% in the SG, whereas it was seen (3/7) 42.9% in the EG. A significant decrease in positive α-smooth muscle actin reaction was observed in ozone-treated group compared with SG.

Conclusion We suggest that ozone can decrease the hepatic destruction levels in experimental model of biliary obstruction.

Keywords

ozone therapy - hepatic fibrosis - biliary tract obstruction

• References

• 1 Kountouras J, Billing BH, Scheuer PJ. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol 1984; 65 (3) 305-311
• 2 Gonzalez-Correa JA, De La Cruz JP, Martin-Aurioles E, Lopez-Egea MA, Ortiz P, Sanchez de la Cuesta F. Effects of S-adenosyl-L-methionine on hepatic and renal oxidative stress in an experimental model of acute biliary obstruction in rats. Hepatology 1997; 26 (1) 121-127
• 3 Tomioka M, Iinuma H, Okinaga K. Impaired Kupffer cell function and effect of immunotherapy in obstructive jaundice. J Surg Res 2000; 92 (2) 276-282
• 4 Sokol RJ, Devereaux M, Khandwala RA. Effect of dietary lipid and vitamin E on mitochondrial lipid peroxidation and hepatic injury in the bile duct-ligated rat. J Lipid Res 1991; 32 (8) 1349-1357
• 5 Aronson DC, de Haan J, James J , et al. Quantitative aspects of the parenchyma-stroma relationship in experimentally induced cholestasis. Liver 1988; 8 (2) 116-126
• 6 Türkdoğan MK, Ozbek H, Yener Z, Tuncer I, Uygan I, Ceylan E. The role of Urtica dioica and Nigella sativa in the prevention of carbon tetrachloride-induced hepatotoxicity in rats. Phytother Res 2003; 17 (8) 942-946
• 7 Re L, Mawsouf MN, Menéndez S, León OS, Sánchez GM, Hernández F. Ozone therapy: clinical and basic evidence of its therapeutic potential. Arch Med Res 2008; 39 (1) 17-26
• 8 Gul H, Uysal B, Cakir E , et al. The protective effects of ozone therapy in a rat model of acetaminophen-induced liver injury. Environ Toxicol Pharmacol 2012; 34 (1) 81-86
• 9 Peralta C, León OS, Xaus C , et al. Protective effect of ozone treatment on the injury associated with hepatic ischemia-reperfusion: antioxidant-prooxidant balance. Free Radic Res 1999; 31 (3) 191-196
• 10 Li CH, Pan LH, Yang ZW, Li CY, Xu WX. Preventive effect of Qianggan-Rongxian Decoction on rat liver fibrosis. World J Gastroenterol 2008; 14 (22) 3569-3573
• 11 Benyon RC, Iredale JP. Is liver fibrosis reversible?. Gut 2000; 46 (4) 443-446
• 12 Chuang JH, Chang NK, Huang CC , et al. Biliary intervention augments chemotactic reaction and aggravates cholestatic liver injury in rats. J Surg Res 2004; 120 (2) 210-218
• 13 Kismet K, Sabuncuoglu MZ, Kilicoglu SS , et al. Effect of propolis on oxidative stress and histomorphology of liver tissue in experimental obstructive jaundice. Eur Surg Res 2008; 41 (2) 231-237
• 14 Padillo FJ, Cruz A, Navarrete C , et al. Melatonin prevents oxidative stress and hepatocyte cell death induced by experimental cholestasis. Free Radic Res 2004; 38 (7) 697-704
• 15 Fehér J, Lengyel G, Blázovics A. Oxidative stress in the liver and biliary tract diseases. Scand J Gastroenterol Suppl 1998; 228: 38-46
• 16 McCord JM. Human disease, free radicals, and the oxidant/antioxidant balance. Clin Biochem 1993; 26 (5) 351-357
• 17 Bocci VA. Scientific and medical aspects of ozone therapy. State of the art. Arch Med Res 2006; 37 (4) 425-435
• 18 Pryor WA. Mechanisms of radical formation from reactions of ozone with target molecules in the lung. Free Radic Biol Med 1994; 17 (5) 451-465
• 19 Bhalla DK, Gupta SK, Reinhart PG. Alteration of epithelial integrity, alkaline phosphatase activity, and fibronectin expression in lungs of rats exposed to ozone. J Toxicol Environ Health A 1999; 57 (5) 329-343
• 20 Gultekin FA, Bakkal BH, Guven B , et al. Effects of ozone oxidative preconditioning on radiation-induced organ damage in rats. J Radiat Res (Tokyo) 2013; 54 (1) 36-44
• 21 Aksu B, Umit H, Kanter M , et al. Effects of methylene blue in reducing cholestatic oxidative stress and hepatic damage after bile-duct ligation in rats. Acta Histochem 2010; 112 (3) 259-269
• 22 Zaky S, Fouad EA, Kotb HI. The effect of rectal ozone on the portal vein oxygenation and pharmacokinetics of propranolol in liver cirrhosis (a preliminary human study). Br J Clin Pharmacol 2011; 71 (3) 411-415